Fig. 5.
Fig. 5. Change of active oxygen-generating ability in patients' neutrophils and surface cytochrome. / b558 expression after IFN-γ treatment. Active oxygen production in neutrophils obtained from the patients at the indicated days after IFN-γ treatment was analyzed by flow cytometry using DHR-123 as a fluorescence probe and PMA as a stimulus. (A) Increase in fluorescence intensity in comparison to control cells was estimated and expressed as percent increase in mean fluorescence. (B) Surface expression of cytochromeb558 in neutrophils at the indicated days were analyzed by flow cytometry after staining with anticytochromeb558 monoclonal antibody 7D5. The lines indicate the mean values.

Change of active oxygen-generating ability in patients' neutrophils and surface cytochrome

b558 expression after IFN-γ treatment. Active oxygen production in neutrophils obtained from the patients at the indicated days after IFN-γ treatment was analyzed by flow cytometry using DHR-123 as a fluorescence probe and PMA as a stimulus. (A) Increase in fluorescence intensity in comparison to control cells was estimated and expressed as percent increase in mean fluorescence. (B) Surface expression of cytochromeb558 in neutrophils at the indicated days were analyzed by flow cytometry after staining with anticytochromeb558 monoclonal antibody 7D5. The lines indicate the mean values.

Close Modal

or Create an Account

Close Modal
Close Modal